Professor Dr. John Wallace

Biography

Dr. Wallace is a widely recognized expert in gastrointestinal inflammation and the development of innovative anti-inflammatory medicines. In the mid-1990s, he co-founded NicOx and chaired its Scientific Advisory Board, which achieved regulatory approval for drugs using gasotransmitters. His research team is credited with identifying the main mechanisms by which NSAIDs damage the stomach and uncovering hydrogen sulfide’s anti-inflammatory properties, leading to the formation of Antibe Therapeutics. His major research interest focuses on the impact of inflammation on tissue injury and repair. His work involves studies of inflammation and ulceration in the gastrointestinal tract, reflecting a long-standing interest in cardiovascular inflammation and platelet function. Dr. Wallace is particularly interested in the identification of novel targets for anti-inflammatory therapies and the subsequent development of these therapies.

Research Interests

Awards